$SPCEBearishMed

Virgin Galactic Crashes 32% on Settlement Dilution Fears, AST SpaceMobile Rises 10%, Planet Labs Climbs 9%

Virgin Galactic (SPCE) fell about 32% after preliminary court approval for a shareholder derivative settlement revived dilution concerns tied to its capital realignment plan, which included debt restructuring and new share issuance. AST SpaceMobile (ASTS) rose about 10% after reaffirming FY2026 revenue guidance of $150M–$200M and confirming three Falcon 9 launches in mid-June. Planet Labs (PL) gained about 9% on quarterly revenue of $81.25M (+33% YoY) and higher remaining performance obligations

9/10
6/10
Med
Bearish
mid-morning reaction; catalysts include mid-June launches
SPCE negative on dilution fear; ASTS/PL positive on guidance/metrics

Settlement approval is being interpreted as higher likelihood of further dilution/cash needs, driving a sharp selloff.

Virgin Galactic got preliminary court approval for a shareholder derivative settlement, reigniting dilution fears tied to its capital realignment plan.

Bearish near-term; elevated volatility likely until runway/dilution details clarify.

Background

The article frames Tuesday’s move as a split between retail-driven proxy trading unwinding and fundamentals-driven bids across the space sector.

Why it matters

SPCE faces a renewed financing/dilution narrative after court-related settlement headlines; ASTS benefits from reaffirmed guidance and confirmed near-term launches; PL benefits from stronger revenue and rapidly rising remaining performance obligations.

Market relevance

Material, company-specific catalysts drove large same-session moves across three US-listed space names.

Market effects

Space stocks are diverging: financing/dilution risk dominates for Virgin Galactic, while operating momentum and backlog/guidance support ASTS and PL.

Primarily US-listed space names; sentiment spillover likely within small/mid-cap space complex.

Reinforces global investor focus on satellite communications execution and funding risk management.

Alternative perspectives

SPCE’s selloff may be sentiment-driven; the stock is still up 55% YTD, suggesting some investors may view dilution fears as already priced.

For ASTS, launch execution risk (schedule slips) could cap upside; for PL, backlog growth may not fully translate to near-term revenue without delivery timing.

Key entities

  • Virgin Galactic

    Preliminary court approval for a shareholder derivative settlement revives dilution/runway concerns.

  • AST SpaceMobile

    Reaffirmed FY2026 revenue guidance and confirmed three Falcon 9 launches in mid-June.

  • Planet Labs

    Quarterly revenue growth and a large jump in remaining performance obligations.

Related articles

$PLMedAI 9/10

Planet Labs Posts Record Quarterly Revenue, Stock Slides Anyway - Planet Labs (NYSE:PL)

Planet Labs reported Q1 adjusted loss of 3 cents per share, better than the 4-cent consensus, and revenue of $94.15 million, above the $89.85 million estimate and up 42% year over year. Remaining performance obligations rose to $816 million and backlog to $906+ million. The company raised FY2027 revenue guidance to $425–$441 million. Shares were down about 7.6% to $40.22.

$PLMedAI 9/10

Planet Labs Q1 Loss Widens, But Revenue Jumps 42%

Planet Labs PBC reported a wider Q1 net loss of $138.9 million ($0.40/share) versus a $12.6 million loss ($0.04/share) a year earlier, largely due to a one-time non-cash $106.5 million charge from revaluing warrant liabilities. Revenue rose 42% to $94.2 million. Adjusted loss was $8.8 million ($0.03/share). The company forecast Q2 revenue of $102–$107 million and FY2027 revenue of $425–$441 million.